Want to see ACB full AI Analyst Report?
Gross Margin by Segment
Indicates the efficiency of each segment in turning revenue into profit, helping investors understand which parts of the business are most cost-effective.Medical margins are Aurora’s clear profit engine—consistently highest and central to results—but have eased back toward the mid‑60s recently. Consumer and plant‑propagation margins are low and inconsistent (management is exiting these low‑margin businesses), while wholesale bulk is highly volatile with recurring negative spikes, signaling pricing pressure or inventory/write‑downs. With a ~30% Canadian reimbursement cut and FY2027 guidance to mid‑to‑high‑50s gross margins, expect near‑term margin compression and more variable EBITDA even as the company reallocates to higher‑margin international capacity.
Date | Medical | Consumer | Wholesale Bulk Cannabis | Plant Propagation |
|---|---|---|---|---|
Jun 30, 2026 | 61.50 | 20.50 | -20.70 | |
Mar 31, 2026 | 66.00 | 22.00 | -30.00 | |
Dec 31, 2025 | 69.00 | 28.00 | 35.00 | 16.00 |
Sep 30, 2025 | 69.00 | 27.00 | 30.00 | 10.00 |
Jun 30, 2025 | 69.00 | 33.00 | 37.00 | 6.00 |
Mar 31, 2025 | 70.00 | 27.00 | 15.00 | 37.00 |
Dec 31, 2024 | 74.00 | 26.00 | 23.00 | 40.00 |
Sep 30, 2024 | 68.00 | 14.00 | -229.00 | 19.00 |
Jun 30, 2024 | 67.00 | 20.00 | -210.00 | 18.00 |
Mar 31, 2024 | 66.00 | 16.00 | -76.00 | 25.00 |